Bio-Rad Laboratories Inc. (BIO)
BIO trades on NYSE in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$363.73
-0.19% on the day
Market cap
$9.7B
Mid cap
Revenue · 2025
$2.6B
+0.7% on 2024
Net income · 2025
$759.9M
29.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BIO on NYSE |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | 1980 |
| SEC CIK | 0000012208 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.6B |
| Net income | $759.9M |
| Operating income | $47.2M |
| Net margin | 29.4% |
| Operating margin | 1.8% |
| Revenue growth | +0.7% |
| Cash | $529.8M |
| Total assets | $10.6B |
| P/E (computed) | 12.8× |
| P/S (computed) | 3.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2022-02-25 |
| Latest annual report | 10-K | 2026-02-13 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-08-04 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-03-25 |
Source: SEC EDGAR submissions feed, 1,007 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.5% |
| 1 month | -4.1% |
| 3 months | +20.4% |
| Year to date | +19.6% |
| 1 year | +19.3% |
| From 52-week high | -7.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| BIO/B | Bio-Rad Laboratories Inc. | $365.08 |
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TXG | 10x Genomics Inc. | $71.79 | -4.52% | $9.4B |
| AVTR | Avantor Inc. | $15.55 | +0.39% | $10.5B |
| BRKR | Bruker Corporation | $56.19 | -0.11% | $8.6B |
| RVTY | Revvity Inc. | $155.08 | -0.34% | $17.3B |
| MTD | Mettler-Toledo International Inc. | $1598.03 | +2.24% | $32.0B |
| WAT | Waters Corporation | $429.17 | -0.68% | $42.2B |
| A | Agilent Technologies Inc. | $171.60 | +0.16% | $48.4B |
| ALMR | Alamar Biosciences Inc. | $23.52 | -2.97% | $1.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier